Amgen Inc

Common Name
Amgen
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
28,000
Ticker
AMGN
Exchange
NASDAQ/NGS
Description
Amgen Inc. is a leading biotechnology company focused on the discovery, development, manufacturing, and marketing of human therapeutics. Established in 1980 and headquartered in Thousand Oaks, Califor...

Amgen's Group Entities Data Preview

As of 12/31/2024, Tracenable has captured detailed data on Amgen's corporate ownership structure, offering an in-depth view of its significant subsidiaries and their importance within the group. a

The dataset includes information on 44 subsidiaries, identified as material based on their financial importance, operational scale, or strategic contribution to Amgen's consolidated operations. a

Entity NameCountryTypeOwnershipLEIPermID
Copy restricted. Please purchase to unlock this data.
a
DEUSubsidiaryNot Specified
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
TURSubsidiaryNot Specified
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CHESubsidiaryNot Specified
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
CANSubsidiaryNot Specified
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
USASubsidiaryNot Specified
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
NLDSubsidiaryNot Specified
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
IRLSubsidiaryNot Specified
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
USASubsidiaryNot Specified
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
JPNSubsidiaryNot Specified
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
USASubsidiaryNot Specified
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
PRISubsidiaryNot Specified
0000000
0000000
Copy restricted. Please purchase to unlock this data.
a
MEXSubsidiaryNot Specified
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
0000000
Showing 12 out of 44 entities. Get complete coverage in the full dataset.
Download Data

Verified Sources Behind Amgen’s Group Entities Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Amgen’s data sources below and access millions more through our Disclosure Search.

a. Amgen's Financial & Extra-Financial Disclosure 2024
a. Amgen's Financial & Extra-Financial Disclosure 2024

Insights into Amgen's Group Entities Location

Tracenable's group entities dataset provides geographic insights into Amgen's significant subsidiaries, revealing their location around the world. a

In total, the Amgen group includes 44 significant subsidiaries distributed across 16 countries, illustrating the company's governance network, operational footprint, and geographical consolidation structure. a

This visualization highlights the geographical distribution of Amgen's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape. a

How geographically diverse is Amgen's corporate structure?

In 2024, Tracenable identified that the Amgen group consisted of 44 significant subsidiaries, located across 16 countries. a

This represents a focused geographic presence, reflecting the company's core operational centers or key strategic markets rather than a full view of its global entity network. a

What does the geographic footprint of Amgen reveal about its business operations?

Amgen's significant subsidiaries are primarily located in North America and Europe, which together host 90.91% of its material entities. a

This concentration suggests that the company's strategic and operational priorities are centered in these key markets, consistent with its focus on financially material or high-impact operations.

How transparent is Amgen about its group entities and ownership structure?

Amgen exhibits a limited level of transparency concerning its corporate ownership structure.

The disclosure covers only a small number of significant subsidiaries, typically those with material financial or operational relevance. a

Without full group hierarchy or equity details, it offers a restricted view of Amgen's broader ownership network, making it harder to assess the company's consolidated structure or cross-entity control.

Does Amgen maintain entities in low-tax or offshore jurisdictions?

Yes. Tracenable's data shows that 2 entities ( 4.55%) are registered in jurisdictions commonly classified as low-tax or offshore financial centers, such as Bermuda. a

This may indicate tax optimization strategies or the use of special-purpose vehicles (SPVs) within Amgen's ownership structure.